Generate Biomedicines, Inc. Common Stock

GENBNASDAQ • USD
10.66 USD
↘ 1.41 (11.70%)🟢LIVE (AS OF 02:00 PM EST)
🟢Market: OPEN

Generate Biomedicines, Inc. Common Stock (GENB) trades at $10.66 per share. Technical indicators currently signal "Strong Sell". This is driven by negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation front, GENB trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Nov 13, 2026.

Open?$11.90
High?$12.16
Low?$10.58
Prev. Close?$12.07
Volume?745.4K
Avg. Volume?980.3K
VWAP?$11.14
Rel. Volume?0.76x
Bid / Ask
Bid?$10.62 × 100
Ask?$10.69 × 100
Spread?$0.07
Midpoint?$10.66
Valuation & Ratios
Market Cap?1.6B
Shares Out?N/A
Float?57.9M
Float %?45.1%
P/E Ratio?N/A
P/B Ratio?4.09
EPS?-$1.74
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
Employees
N/A
Market Cap
1.6B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2026-02-27
Address
101 SOUTH STREET, SUITE 900
SOMERVILLE, MA 02143
Phone: 888-469-0055
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?15.69%High
Short Interest?9.1M
Days to Cover?8.9
Free Float57.9M
Avg Daily Volume1.0M
Settlement Date2026-10-30
Financial Health
Current Ratio?5.01Strong
Quick Ratio?5.01Strong
Cash Ratio?1.70Strong
Debt/Equity?0.05Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
44
4.09FAIR▾
P/S?
Peers
100
S&P
3
87.75HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-6.6CHEAP▾
EV/Sales?
Peers
100
S&P
3
80.88HIGH▾
Returns & Efficiency
ROE?
S&P
3
-58.8%WEAK▾
ROA?
S&P
3
-43.4%WEAK▾
Cash Flow & Enterprise
FCF?$-248722000
Enterprise Value?$1.4B
Fundamentals ratios updated end of day